Clinical Inquiries

How often does long-term PPI therapy cause clinically significant hypomagnesemia?

Author and Disclosure Information

 

References

A comparison of the use of loop diuretics and thiazides by patients taking PPIs found that concurrent use of loop diuretics increased serum magnesium reduction (−0.08 mg/dL; 95% CI, −0.14 to −0.02), but thiazides didn’t. Numbers were small: Of the 45 participants taking both a PPI and a loop diuretic, only 5 had hypomagnesemia (OR=7.2; 95% CI, 1.7-30.8).3

RECOMMENDATIONS

In 2011, the US Food and Drug Administration (FDA) warned of a possible increased risk of hypomagnesemia in patients taking PPIs long-term. The FDA advisory panel recommended evaluating serum magnesium before beginning long-term PPI therapy and in patients concurrently taking diuretics, digoxin, or other medications associated with hypomagnesemia.6

Pages

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

What’s the best secondary treatment for patients who fail initial triple therapy for H pylori?
MDedge Family Medicine
Even modest alcohol use may worsen NAFLD
MDedge Family Medicine
Weight gain linked to progression of fibrosis in NAFLD patients
MDedge Family Medicine
Genetic composition of HCV changes with HIV coinfection
MDedge Family Medicine
Immunosuppression often triggers skin side effects
MDedge Family Medicine
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
MDedge Family Medicine
Prepare for ‘the coming tsunami’ of NAFLD
MDedge Family Medicine
Mailing out fecal tests may improve CRC screening rates
MDedge Family Medicine
Should PCPs take over chronic HCV treatment?
MDedge Family Medicine
AGA Guideline: Treatment of opioid-induced constipation
MDedge Family Medicine